Professor Hilgendorf is clinical director of the Department of Cardiology, Angiology and Intensive Care Medicine, German Heart Center Charité in Berlin. He works as an interventional cardiologist and engages in translational studies and clinical trials in the field of lipid therapy, heart failure, immunomodulation, and coronary and structural heart disease. Following his postdoctoral training at the MGH Center for Systems Biology, Boston, MA, USA, he established his own research group in Freiburg, Germany, studying the role of the innate and adaptive immune system in cardiovascular disease and the impact of traditional and non-traditional risk factors.
